Search Results

You are looking at 1 - 10 of 110 items for :

  • "follicular" x
  • All content x
Clear All
Full access

Rupali Roy and Leo I. Gordon

With the development of monoclonal antibodies and their use in combination with chemotherapy for the treatment of follicular lymphoma, median survival of patients has increased. 1 – 4 Much focus has been directed to investigating rituximab in the

Full access

Edward A. Faber Jr. and Julie M. Vose

. Learning Objectives Upon completion of this activity, participants will be able to: • Describe overall and progression-free survival associated with treatment of follicular lymphoma • Compare the benefits of in vitro graft purging vs no purging when

Full access

Caron A. Jacobson and Arnold S. Freedman

!” This lyric from the Grateful Dead is relevant to the patient with asymptomatic follicular lymphoma (FL). If the goal of management of patients with advanced-stage FL is survival, then observation for many newly diagnosed patients is not dead. Most

Full access

Richard I. Fisher

In the past several decades, tremendous progress has been made in the treatment of follicular lymphoma (FL), as evidenced by the multiple treatment options available. According to Richard I. Fisher, MD, President, Chief Executive Officer, and

Full access

Richard I. Fisher and Nadia Khan

after being diagnosed with follicular lymphoma (FL). The reasons for the decision not to treat were complex and not entirely evident on review, but included assessment by the treating oncologists that these patients presented with a benign or indolent

Full access

Steven G. Waguespack and Gary Francis

during adolescence that is not seen in young children. 2 – 7 Most thyroid cancers in children are papillary (PTC), followed by follicular (FTC) and, more rarely, medullary carcinoma. 5 , 8 – 10 Subtypes of PTC include follicular variant, tall cell

Full access

Mathias Rummel

types are diffuse large B-cell lymphoma (DLBCL; 31%) and follicular lymphoma (FL; 22%; ( Figure 1 ). 2 More than 65,000 new cases of NHL develop each year, and approximately 20,000 people with NHL will die in 2009. 3 NHL is the seventh most common

Full access

Nina D. Wagner-Johnston and Nancy L. Bartlett

) rate is 65% to 70% with more than 80% of relapses occurring within the first 3 years and only 10% after 5 years. 14 , 15 In contrast, the 2-year PFS rate for follicular lymphoma is approximately 80%, with a relatively constant rate of relapse at 8% to

Full access

Presenter: Stephen D. Smith

, follicular lymphoma; MALT, mucosa-associated lymphoid tissue; MCL, mantle cell lymphoma; MZL, marginal zone lymphoma. a MYD88 L265P mutation can be present in MZL (10%–20%). General Principles of First-Line Treatment Similar to follicular lymphoma